President Joe Biden’s executive order to bolster competition includes 72 initiatives by more than a dozen federal agencies, affecting everything from restricting noncompete agreements for workers to allowing imports of prescription drugs from Canada.
While there’s a long way to go from a presidential directive to final regulations, the president’s directive seeks to address the sharp increase in consolidation of industries over the last two decades, which has raised worries that the biggest companies are choking off competition and innovation.
The White House blames declining competition across the economy for raising prices of necessities like prescription drugs, lowering wages ...